U.K. Research Authority To Review 'Confusing' Trial Registration Requirements
This article was originally published in The Pink Sheet Daily
Executive Summary
Richmond Pharmacology prevails in its judicial challenge to HRA's requirements to register previous trials, but much of the debate evolved to focus on discrepancies in language.